Abstract
The competing endogenous RNA (ceRNA) activity of long non-coding RNAs (lncRNAs) has profound effects in pathological disorders, including Parkinson’s disease. Here, we focused on the LINC00943-mediated ceRNA network for the regulation of LINC00943 in MPP+ toxicity in SK-N-SH cells. SK-N-SH cells were exposed to 1-methyl-4-phenylpyridinium (MPP+). LINC00943, miR-671-5p and ELAV like RNA binding protein 1 (ELAVL1) were quantified by real-time quantitative PCR (RT-qPCR) or western blot. Cell viability and apoptosis were gauged by Cell Counting Kit-8 (CCK-8) assay and flow cytometry, respectively. Direct relationship between miR-671-5p and LINC00943 or ELAVL1 was confirmed by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. Our data validated that LINC00943 regulated MPP+-evoked injury in SK-N-SH cells. LINC00943 regulated miR-671-5p expression by binding to miR-671-5p. Moreover, miR-671-5p was identified as a molecular mediator of LINC00943 in regulating SK-N-SH cell injury induced by MPP+. MiR-671-5p targeted and inhibited ELAVL1, and miR-671-5p-mediated inhibition of ELAVL1 impacted MPP+-evoked SK-N-SH cell injury. Furthermore, LINC00943 involved the post-transcriptional regulation of ELAVL1 through miR-671-5p competition. Our present study has established a novel mechanism, the LINC00943/miR-671-5p/ELAVL1 ceRNA crosstalk, for the regulation of LINC00943 on MPP+ toxicity in SK-N-SH cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
References
Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4. https://doi.org/10.7554/eLife.05005
Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol 15:1257–1272. https://doi.org/10.1016/s1474-4422(16)30230-7
Barbagallo D, Condorelli A, Ragusa M, Salito L, Sammito M, Banelli B, Caltabiano R, Barbagallo G, Zappalà A, Battaglia R, Cirnigliaro M, Lanzafame S, Vasquez E, Parenti R, Cicirata F, Di Pietro C, Romani M, Purrello M (2016) Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme. Oncotarget 7:4746–4759. https://doi.org/10.18632/oncotarget.6621
Chen L, Huang H, Chen L, Xu L, Chen J, Lu Q (2021) Circ-PTTG1IP/miR-671-5p/TLR4 axis regulates proliferation, migration, invasion and inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis. Gen Physiol Biophys 40:207–219. https://doi.org/10.4149/gpb_2021014
Choi HJ, Yang H, Park SH, Moon Y (2009) HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol. Toxicol Appl Pharmacol 240:46–54. https://doi.org/10.1016/j.taap.2009.06.023
Cook C, Stetler C, Petrucelli L (2012) Disruption of protein quality control in Parkinson's disease. Cold Spring Harb Perspect Med 2:a009423. https://doi.org/10.1101/cshperspect.a009423
Deng L, Guo Y, Liu J, Wang X, Chen S, Wang Q, Rao J, Wang Y, Zuo T, Hu Q, Zhao X, Dong Z (2021) miR-671-5p attenuates Neuroinflammation via suppressing NF-κB expression in an acute ischemic stroke model. Neurochem Res 46:1801–1813. https://doi.org/10.1007/s11064-021-03321-1
Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12:861–874. https://doi.org/10.1038/nrg3074
Goh SY, Chao YX, Dheen ST, Tan EK, Tay SS (2019) Role of MicroRNAs in Parkinson's disease. Int J Mol Sci 20. https://doi.org/10.3390/ijms20225649
Hayes MT (2019) Parkinson's disease and parkinsonism. Am J Med 132:802–807. https://doi.org/10.1016/j.amjmed.2019.03.001
Jeyabal P, Thandavarayan RA, Joladarashi D, Suresh Babu S, Krishnamurthy S, Bhimaraj A, Youker KA, Kishore R, Krishnamurthy P (2016) MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem Biophys Res Commun 471:423–429. https://doi.org/10.1016/j.bbrc.2016.02.065
Konovalova J, Gerasymchuk D, Parkkinen I, Chmielarz P, Domanskyi A (2019) Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases. Int J Mol Sci 20. https://doi.org/10.3390/ijms20236055
Lebedeva S, Jens M, Theil K, Schwanhäusser B, Selbach M, Landthaler M, Rajewsky N (2011) Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell 43:340–352. https://doi.org/10.1016/j.molcel.2011.06.008
Li JH, Liu S, Zhou H, Qu LH, Yang JH (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92–D97. https://doi.org/10.1093/nar/gkt1248
Li X, Zeng L, Cao C, Lu C, Lian W, Han J, Zhang X, Zhang J, Tang T, Li M (2017) Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res 350:327–335. https://doi.org/10.1016/j.yexcr.2016.12.006
Li J, Sun Y, Chen J (2019) Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson's disease. Genes Genet Syst 94:61–69. https://doi.org/10.1266/ggs.18-00036
Lian H, Wang B, Lu Q, Chen B, Yang H (2021) LINC00943 knockdown exerts neuroprotective effects in Parkinson's disease through regulates CXCL12 expression by sponging miR-7-5p. Genes Genomics 43:797–805. https://doi.org/10.1007/s13258-021-01084-1
Lien GS, Liu JF, Chien MH, Hsu WT, Chang TH, Ku CC, Ji AT, Tan P, Hsieh TL, Lee LM, Ho JH (2014) The ability to suppress macrophage-mediated inflammation in orbital fat stem cells is controlled by miR-671-5p. Stem Cell Res Ther 5:97. https://doi.org/10.1186/scrt486
Liu T, Zhang Y, Liu W, Zhao J (2021) LncRNA NEAT1 regulates the development of Parkinson's disease by targeting AXIN1 via sponging miR-212-3p. Neurochem Res 46:230–240. https://doi.org/10.1007/s11064-020-03157-1
Lotankar S, Prabhavalkar KS, Bhatt LK (2017) Biomarkers for Parkinson's disease: recent advancement. Neurosci Bull 33:585–597. https://doi.org/10.1007/s12264-017-0183-5
Marchese D, Botta-Orfila T, Cirillo D, Rodriguez JA, Livi CM, Fernández-Santiago R, Ezquerra M, Martí MJ, Bechara E, Tartaglia GG (2017) Discovering the 3' UTR-mediated regulation of alpha-synuclein. Nucleic Acids Res 45:12888–12903. https://doi.org/10.1093/nar/gkx1048
Meng C, Gao J, Ma Q, Sun Q, Qiao T (2021) LINC00943 knockdown attenuates MPP(+)-induced neuronal damage via miR-15b-5p/RAB3IP axis in SK-N-SH cells. Neurol Res 43:181–190. https://doi.org/10.1080/01616412.2020.1834290
Qin L, Min S, Shu L, Pan H, Zhong J, Guo J, Sun Q, Yan X, Chen C, Tang B, Xu Q (2020) Genetic analysis of N6-methyladenosine modification genes in Parkinson's disease. Neurobiol Aging 93:143.e149–143.e113. https://doi.org/10.1016/j.neurobiolaging.2020.03.018
Riva P, Ratti A, Venturin M (2016) The long non-coding RNAs in neurodegenerative diseases: novel mechanisms of pathogenesis. Curr Alzheimer Res 13:1219–1231. https://doi.org/10.2174/1567205013666160622112234
Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell 146:353–358. https://doi.org/10.1016/j.cell.2011.07.014
Schultz CW, Preet R, Dhir T, Dixon DA, Brody JR (2020) Understanding and targeting the disease-related RNA binding protein human antigen R (HuR). Wiley Interdiscip Rev RNA 11:e1581. https://doi.org/10.1002/wrna.1581
Tan X, Li Z, Ren S, Rezaei K, Pan Q, Goldstein AT, Macri CJ, Cao D, Brem RF, Fu SW (2019) Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer. Breast Cancer Res 21:89. https://doi.org/10.1186/s13058-019-1173-5
Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505:344–352. https://doi.org/10.1038/nature12986
Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H (2019) Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease. Mol Brain 12:49. https://doi.org/10.1186/s13041-019-0471-2
Wu YY, Kuo HC (2020) Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases. J Biomed Sci 27:49. https://doi.org/10.1186/s12929-020-00636-z
Yang H, Lin Q, Chen N, Luo Z, Zheng C, Li J, Zheng F, Guo Z, Cai P, Wu S, Wang YL, Li H (2020) LncRNA NR_030777 alleviates Paraquat-induced neurotoxicity by regulating Zfp326 and Cpne5. Toxicol Sci 178:173–188. https://doi.org/10.1093/toxsci/kfaa121
Zhang LM, Wang MH, Yang HC, Tian T, Sun GF, Ji YF, Hu WT, Liu X, Wang JP, Lu H (2019) Dopaminergic neuron injury in Parkinson's disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b/ α-synuclein pathway. Aging (Albany NY) 11:9264–9279. https://doi.org/10.18632/aging.102330
Zhang Q, Huang XM, Liao JX, Dong YK, Zhu JL, He CC, Huang J, Tang YW, Wu D, Tian JY (2020) LncRNA HOTAIR promotes neuronal damage through facilitating NLRP3 mediated-Pyroptosis activation in Parkinson's disease via regulation of miR-326/ELAVL1 Axis. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-020-00946-8
Zhang Q, Huang XM, Liao JX, Dong YK, Zhu JL, He CC, Huang J, Tang YW, Wu D, Tian JY (2021a) LncRNA HOTAIR promotes neuronal damage through facilitating NLRP3 mediated-Pyroptosis activation in Parkinson's disease via regulation of miR-326/ELAVL1 Axis. Cell Mol Neurobiol 41:1773–1786. https://doi.org/10.1007/s10571-020-00946-8
Zhang H, Wang Z, Hu K, Liu H (2021b) Downregulation of long noncoding RNA SNHG7 protects against inflammation and apoptosis in Parkinson's disease model by targeting the miR-425-5p/TRAF5/NF-κB axis. J Biochem Mol Toxicol 35:e22867. https://doi.org/10.1002/jbt.22867
Zhang J, Yang Y, Zhou C, Zhu R, Xiao X, Zhou B, Wan D (2022) LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease. Bioengineered 13:4493–4516. https://doi.org/10.1080/21655979.2022.2033409
Zhao J, Li H, Chang N (2020) LncRNA HOTAIR promotes MPP+-induced neuronal injury in Parkinson's disease by regulating the miR-874-5p/ATG10 axis. EXCLI J 19:1141–1153. https://doi.org/10.17179/excli2020-2286
Zheng Y, Liu J, Zhuang J, Dong X, Yu M, Li Z (2021) Silencing of UCA1 protects against MPP(+)-induced cytotoxicity in SK-N-SH cells via modulating KCTD20 expression by sponging miR-423-5p. Neurochem Res 46:878–887. https://doi.org/10.1007/s11064-020-03214-9
Zhou S, Zhang D, Guo J, Chen Z, Chen Y, Zhang J (2021) Deficiency of NEAT1 prevented MPP(+)-induced inflammatory response, oxidative stress and apoptosis in dopaminergic SK-N-SH neuroblastoma cells via miR-1277-5p/ARHGAP26 axis. Brain Res 1750:147156. https://doi.org/10.1016/j.brainres.2020.147156
Zhu Z, Luo L, Xiang Q, Wang J, Liu Y, Deng Y, Zhao Z (2020) MiRNA-671-5p promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis. Cell Death Dis 11:949. https://doi.org/10.1038/s41419-020-03138-w
Author information
Authors and Affiliations
Contributions
Ning Luan designed and performed the research; Ning Luan and Jian Shi analyzed the data; Xuejie Zhang wrote the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Disclosure of interest
The authors declare that they have no conflicts of interest.
Ethics approval and consent to participate
Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of The First Affiliated Hospital of Jinzhou Medical University.
Consent for publication
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, X., Luan, N. & Shi, J. A novel LINC00943/miR-671-5p/ELAVL1 ceRNA crosstalk regulates MPP+ toxicity in SK-N-SH cells. Metab Brain Dis 37, 2349–2362 (2022). https://doi.org/10.1007/s11011-022-01034-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-01034-0